• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: August 2023

Pharma & Human Health

Lonza’s Capsugel® Enprotect® capsule for effective enteric delivery

August 31, 2023 Microbiome Times

Orally delivered APIs must survive the harsh acidic conditions of the upper gastrointestinal tract to reach their target destination and remain viable. To overcome this challenge Lonza Capsules & Health Ingredients have developed groundbreaking enteric […]

Pharma & Human Health

Anti-bacterial virus treated antibiotic resistant infections with 86.6% success rate

August 24, 2023 Microbiome Times

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The […]

Editor's Choice

Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023

August 22, 2023 Daniel Quinn

The composition and metabolic output of the human gut microbiome is shaped by several environmental factors, an important one being diet. To better understand the relationship between diet and microbiome function researchers must develop methods […]

Pharma & Human Health

New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population

August 22, 2023 Lavita Vaz and Irene Cisma Diaz

Asthma is a major cause of disability, poor quality of life world-wide and health resource utilization. The World Health Organisation (WHO) estimated that 262 million people suffered from asthma in 2019 and it caused 455 […]

Finance

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial

August 18, 2023 Microbiome Times

Bloom Science, Inc., a clinical-stage, central nervous system (CNS) company focused on discovering and developing breakthrough therapeutics that target the Gut-Brain Axis for neurological diseases, today announced positive results from its Phase 1 clinical study […]

Pharma & Human Health

A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome

August 17, 2023 Microbiome Times

Aspergillus fumigatus strains that infect humans have a significantly altered metabolism compared to other strains in the environment. At the same time, infection with the fungus leads to an apparent change in the human lung microbiome. […]

Pharma & Human Health

Multiple sclerosis: fateful immune cell activation in gut made visible

August 15, 2023 Microbiome Times

Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. It is triggered by certain T cells, which infiltrate the brain and spinal cord and attack the insulating myelin sheath around axons. […]

Pharma & Human Health

Engineered probiotic developed to treat multiple sclerosis

August 14, 2023 Microbiome Times

Brigham researchers are working on a new approach to target autoimmunity in the brain leverages designer bacteria to make treatment safer and more effective Researchers  from Brigham and Women’s Hospital, a founding member of the Mass General […]

Finance

Bactolife Raises EUR 30 million in Series A Financing

August 8, 2023 Microbiome Times

Bactolife A/S (“Bactolife”), a bioindustrial company developing proprietary Binding ProteinsTM, which strengthen the gut microbiome of humans and animals with the aim of reducing the burden of gastrointestinal infections and anti-microbial resistance, today announced that […]

Sign Up to Free Newsletter

Editor’s Choice

  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
sign up

Sign up to the Microbiome Times newsletter